Evidence map›Paper›PMID 39868296›Full record

ArticlebioRxiv : the preprint server for biology2025

Community assembly modeling of microbial evolution within Barrett's esophagus and esophageal adenocarcinoma.

Caitlin Guccione, Igor Sfiligoi, Antonio Gonzalez, Justin P Shaffer, Mariya Kazachkova, Yuhan Weng, Daniel McDonald, Shailja C Shah, Samuel S Minot, Thomas Paulson and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Caitlin GuccioneDivision of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Igor SfiligoiSan Diego Supercomputer Center, University of California San Diego, La Jolla, CA, USA.
Antonio GonzalezDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Justin P ShafferDepartment of Biology, California State University, Fresno, CA, USA.
Mariya KazachkovaMoores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Yuhan WengBioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA.
Daniel McDonaldDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Shailja C ShahMoores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Samuel S MinotData Core, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Thomas PaulsonTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
William M GradyTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Ludmil B AlexandrovMoores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Rob KnightDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Kit CurtiusDivision of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-2678-0960

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007198 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, INSEL, PAUL A · 1985 to 2024
$29.3M
UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagusU2CCA271902 · NCI · FRED HUTCHINSON CANCER CENTER · PI Cecilia C Yeung · 2022 to 2026
$5.3M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
Bacterial biosensors for the prevention of gastrointestinal cancersR01CA241728 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEFF M HASTY, ROB KNIGHT · 2020 to 2026
$4.2M
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)U24CA248454 · NCI · NORTHERN ARIZONA UNIVERSITY · PI CAPORASO, JAMES GREGORY · 2020 to 2024
$3.7M
Multiscale modeling of spatiotemporal evolution in Barrett's esophagusR01CA270235 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kathleen M. Curtius · 2023 to 2026
$2.3M
The microbiome ecosystem of Barrett's esophagus and progression to cancerR21CA259687 · NCI · FRED HUTCHINSON CANCER CENTER · PI PAULSON, THOMAS G · 2022 to 2023
$407k
CSRD VA IK2 CX002027NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA140657NCI NIH HHS R01 CA241728NCI NIH HHS R01 CA270235NCI NIH HHS R21 CA259687NCI NIH HHS U24 CA248454NCI NIH HHS U2C CA271902NIDDK NIH HHS P30 DK120515NIGMS NIH HHS K12 GM068524NIGMS NIH HHS T32 GM007198
6 · The paper itself

Abstract

Mathematical modeling of somatic evolution, a process impacting both host cells and microbial communities in the human body, can capture important dynamics driving carcinogenesis. Here we considered models for esophageal adenocarcinoma (EAC), a cancer that has dramatically increased in incidence over the past few decades in Western populations, with high case fatality rates due to late-stage diagnoses. Despite advancements in genomic analyses of the precursor Barrett's esophagus (BE), prevention of late-stage EAC remains a significant clinical challenge. Previous microbiome studies in BE and EAC have focused on quantifying static microbial abundance differences rather than evolutionary dynamics. Using whole genome sequencing data from esophageal tissues, we first applied a robust bioinformatics pipeline to extract non-host DNA reads, mapped these putative reads to microbial taxa, and retained those taxa with high genomic coverage. When applying mathematical models of microbial evolution to sequential stages of progression to EAC, we observed evidence of neutral dynamics in community assembly within normal esophageal tissue and BE, but not EAC. In a case-control study of BE patients who progressed to EAC cancer outcomes (CO) versus those who had non-cancer outcomes (NCO) during follow-up (mean=10.5 years), we found that

Indexed as

Barrett’s esophaguscancer microbiomecommunity assemblyEsophageal adenocarcinomaHelicobacter pylorimathematical modeling

Identifiers

PMID39868296
PMCPMC11760701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.